Hyperlipidemia, Familial CombinedHyperlipidemiasLipid MetabolismTriglyceridesEnergy MetabolismLipidsCholesterolHypolipidemic AgentsLiverHypertriglyceridemiaCholesterol, LDLLipoproteinsGlucoseApolipoproteins EHyperlipoproteinemia Type IVApolipoproteins BHypercholesterolemiaMetabolismCholesterol, HDLApolipoproteins CLipoprotein LipaseLipoproteins, VLDLApolipoprotein C-IIIApolipoprotein E2FenofibrateBlood GlucoseAnticholesteremic AgentsDietary FatsInsulinXanthomatosisObesityLipoproteins, LDLArteriosclerosisApolipoproteinsFatty AcidsCholesterol, VLDLReceptors, LDLMice, Inbred C57BLHydroxymethylglutaryl-CoA Reductase InhibitorsRisk FactorsOxidation-ReductionBody WeightInsulin ResistanceHyperlipoproteinemia Type IIGynostemmaFatty Acids, NonesterifiedAtherosclerosisTime FactorsApolipoprotein A-IMice, KnockoutBiotransformationDiabetes MellitusHyperlipoproteinemia Type IIICholesterol, DietaryPostprandial PeriodFatty LiverHeptanoic AcidsPoloxamerDiet, AtherogenicDietDiabetes Mellitus, Type 2Disease Models, AnimalHypertensionAdipose TissueMicrosomes, LiverCytochrome P-450 Enzyme SystemRats, Sprague-DawleyPhenotypeDyslipidemiasBezafibrateApolipoproteins AGlycolysisKineticsMetabolic Networks and PathwaysRNA, MessengerSimvastatinLipaseHyperlipoproteinemiasPyrrolesChylomicronsLipolysisDiet, High-FatEpichlorohydrinMetabolism, Inborn ErrorsHyperglycemiaModels, BiologicalGene Expression RegulationCardiovascular DiseasesRats, WistarChromatography, High Pressure LiquidRats, Inbred StrainsApolipoprotein B-48Nephrotic SyndromeLipoproteins, IDLApolipoprotein E3FastingGemfibrozilHyperlipoproteinemia Type VApolipoprotein A-IIOxygen Consumption